posted on 2023-03-10, 09:53authored byArchontissa Kanavaki, Jared Palmer, Courtney J Lightfoot, Thomas Wilkinson, Roseanne E Billany, Alice Smith
Background and Aims
Patients with non-dialysis chronic kidney disease (CKD patients) require specialised management, including routine clinical visits, laboratory measures, and medication adjustments. Inevitably, the COVID-19 pandemic has resulted in changes to delivery of care in a bid to prevent virus transmission in this clinically vulnerable group. The extent of the impact of any changes in support provision for patients is largely unknown. The study aimed to capture the views of CKD patients, family or other significant person in their lives (SO), and nephrology healthcare professionals (HCPs) on how patients’ healthcare needs were and could be supported during this time.
History
Author affiliation
Department of Health Sciences, University of Leicester
Source
58th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA)